JNCE 1.88 (+0%)
US4811161011BiotechnologyBiotechnology

Jounce Therapeutics (JNCE) Financial Metrics

This table shows a selected set of financial data points of Jounce Therapeutics (JNCE). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2022 -0.99 0 -1.13 57.38M -0.22 82M -29.8M -50.16M -50.92M 150.57M
2021 -1.82 0 -4.59 416.92M -0.37 26.91M -83.87M -91.06M -90.87M 95.53M
2020 -1.24 0 -5.66 247.98M -0.19 62.34M -27.88M -45.12M -43.84M 147.49M
2019 1.66 0 5.27 299.39M 0.27 147.87M -31.11M 52.82M 56.82M 53.24M
2018 -0.84 0 -4.01 109.75M -0.11 65.2M -64.97M -23.5M -27.38M 47.91M
2017 -0.55 0 -23.3 383.2M -0.06 71.64M -105.85M -11.99M -16.44M 23.56M
2016 -0.45 0 0 0 -0.08 37.2M 177.47M -11.76M -13.7M 44.85M
2015 -1.54 0 0 0 -0.94 0 -27.94M -27.06M -28.53M 45.16M
2014 -0.48 0 0 0 0 0 -15.61M -9.41M -10.52M 2.34M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.